ArticleJournal of neuroinflammation2017

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.

Mohan S Maddur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.